ACTU: Nilai perusahaan marang bathi resik Actuate Therapeutics Inc.

Actuate Therapeutics Inc. - logo grafis emiten ACTU

The market trend for Actuate Therapeutics, Inc. (ACTU) shares on the GURU.Markets platform, where the indicator stands at -0.40, is driven by the success of complex tumor therapies and the pace of subject group formation. Current quotes price in R&D costs and the anticipation of Phase II trial results. In the long term, the business is based on the global promotion of elraglusib to capture market share within the oncology sector.

Koefisien rega marang bathi: Actuate Therapeutics, Inc. (ACTU) kanggo 21.03.2025 - 16.11.2026

Rincian metrik komprehensif lan analitis Actuate Therapeutics Inc. (ACTU)

Ringkesan analisis perusahaan:ACTU, Actuate Therapeutics
Barang unggulan Actuate Therapeutics

The P/E ratio reflects the market value of a business relative to its generated net income. Analyzing the annual P/E of a company allows an investor to quickly diagnose asset overvaluation and debt service risks. The trend of this ratio on the chart serves as an indicator of the balance between the cost of capital and growth rates. For Actuate Therapeutics, Inc. (ACTU), a high valuation is often justified by its scientific mission and the value of option packages used to retain leading oncologists.

Pesaing wigati

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme Inc.)|RVMD (RevMed) - Nilai perusahaan marang bathi resik|Pangali P/E AAPG (ascentage.com)|CGON - Koefisien rega marang bathi|URGN: Koefisien rega marang bathi|BCAX - Pangali P/E|Personalis Corp (PSNL) - Rasio rega marang bathi|Erasca Corp - Nilai perusahaan marang bathi resik|DCTH (Delcath Systems Inc) - Pangali P/E|Kapitalisasi marang bathi Y-mAbs Therapeutics, Inc. YMAB|Pangali P/E AURA|Koefisien rega marang bathi Candel Therapeutics, Inc. CADL|Pangali P/E ARAY (Accuray, Inc.)|SELLAS Life Sciences - Rasio rega marang bathi|CTOR: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Koefisien rega marang bathi|Kapitalisasi marang bathi Fate Therapeutics Corp (FATE)|Koefisien rega marang bathi WHWK|Pangali rega marang bathi TCRX (TScan Therapeutics, Inc.)|Pangali P/E CSBR|XBIT - Kapitalisasi marang bathi|CEL-SCI Corporation - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik OSTX|radiopharmtheranostics.com - Pangali P/E|ARTV: Rasio rega marang bathi|ANL (adlainortye.com) - Koefisien rega marang bathi|VERU - Periode bali modal bisnis|TPST (Tempest Therapeutics, Inc.) - Pangali P/E|Pangali P/E xiliotx.com|Rasio rega marang bathi Enochian BioSciences (RENB)|Rasio rega marang bathi MURA (Mural Oncology PLC)|Rasio rega marang bathi Kairos Pharma Ltd KAPA|Pangali P/E OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Pangali P/E|Periode bali modal bisnis Curis CRIS|APLM: Pangali P/E|Koefisien rega marang bathi Tharimmune, Inc.|ADVB (Advanced Biomed) - Pangali P/E|Genprex - Kapitalisasi marang bathi resik|Rasio rega marang bathi calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Nilai perusahaan marang bathi resik|Pangali P/E XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalisasi marang bathi|PPBT: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Rasio rega marang bathi|Checkpoint Therapeutics, Inc (CKPT) - Pangali P/E|Rasio rega marang bathi Elevation Oncology, Inc.|ICAD: Nilai perusahaan marang bathi resik|Rasio rega marang bathi ikenaoncology.com (IKNA)|Rasio rega marang bathi NTBL (Notable Labs, Ltd.)|Pangali P/E VIRX (viracta.com)|MOR - Koefisien rega marang bathi|NAYA - Rasio rega marang bathi|Kapitalisasi marang bathi resik AAPGV